Healthtech funding in H1 2025
European Healthtech startup funding raised during H1 2025.
In H1 2025, 237 European Healthtech companies closed 239 funding rounds and raised €4.0B in equity funding (excluding debt and grants), up 76.9% versus H1 2024. Debt rounds added €20M. UK led by capital raised, and Venture Kick was the most active investor. Data as of 20 Nov 2026.
Equity funding
€4.0B
+76.9% vs H1 2024 · excl. debt & grants · +€20M debt
Funding rounds
239
+7.2% vs H1 2024
Companies
237
Top country
UK
Rank among sectors
#3
11.8% of sector funding
Debt financing
€20M
0.5% of total
Top-10 round share
53.1%
of disclosed capital
Rounds ≥ €100M
10
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H1 2025 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €1.5B | 35 |
| Feb | €214M | 44 |
| Mar | €804M | 33 |
| Apr | €427M | 39 |
| May | €739M | 47 |
| Jun | €360M | 41 |
Top countries
by € raisedHealthtech — top countries by capital, H1 2025 — interactive chart.
Data table
| Healthtech — top countries by capital, H1 2025 | |
|---|---|
| UK | €1.6B |
| Switzerland | €567M |
| Netherlands | €335M |
| Sweden | €273M |
| Spain | €250M |
| France | €226M |
| Ireland | €180M |
| Denmark | €148M |
Stage mix
by € raisedHealthtech — stage mix, H1 2025 — interactive chart.
Data table
| Healthtech — stage mix, H1 2025 | |
|---|---|
| Other | €1.6B |
| Series A | €1.1B |
| Series B | €866M |
| Series C | €186M |
| Seed | €135M |
| Grant | €40M |
| Pre-Seed | €25M |
| Debt | €20M |
| Early VC | €2.1M |
| Growth/Late | €2.0M |
| Crowdfunding | €460k |
Exits & M&A
14 Acquisition14 exits.
Top deals
largest disclosed rounds in H1 2025| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Other | Mar 2025 | €555M |
| Verdiva Bio | Series A | Jan 2025 | €399M |
| Neko Health | Series B | Jan 2025 | €250M |
| CMR Surgical | Other | Apr 2025 | €185M |
| Cera | Other | Jan 2025 | €150M |
| Azafaros | Series B | May 2025 | €132M |
| SpliceBio | Series B | Jun 2025 | €118M |
| CeQur | Other | Jan 2025 | €116M |
| Fire1 | Other | Jan 2025 | €115M |
| GlycoEra | Series B | May 2025 | €114M |
| Orbis Medicines | Series A | Jan 2025 | €90M |
| Mosanna Therapeutics | Series A | Jun 2025 | €70M |
| Leyden Labs | Other | Jan 2025 | €68M |
| Juvenescence | Series B | May 2025 | €67M |
| Maxion Therapeutics | Series A | Mar 2025 | €66M |
Top investors
most active in H1 2025, by deal count- Venture Kick8 deals
- Forbion5 deals
- High-Tech Gründerfonds (HTGF)5 deals
- Novo Holdings5 deals
- Bayern Kapital4 deals
- Business Finland4 deals
- Eli lilly and company4 deals
- LUMO labs4 deals
- Voima Ventures4 deals
- Almi Invest3 deals